Surfacide Helios Multiple Emitter UV-C Disinfection System
Surfacide’s Helios Multiple Emitter UV-C Disinfection System, primarily used in hospitals, is now available to a range of Australian and New Zealand businesses to help them give customers confidence in the cleanliness of hard surfaces as coronavirus restrictions are lifted.
The UV-C disinfection technology emits UV-C energy to kill coronaviruses, influenza, staph, fungus, mould and bacteria, plus a multitude of other drug-resistant organisms. Multiple emitters are placed in an area and, through a process of laser mapping, all high-touch surfaces within the area are disinfected. Depending on the size of the area, this can be completed in as little as 5 min. Surfacide provides a detailed record of the disinfection process, with real-time analytics available via a cloud-based portal.
The chemical-free disinfection system originates from the USA and is trusted by over 500 hospitals worldwide. It is used in operating theatres and wards where the highest standard of disinfection is required to reduce healthcare-associated infections (HIA). It is claimed to reduce acquired infections by 99.9999% and conforms with Australian Therapeutic Goods Regulations.
Phone: 1300 048 447
AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists
AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide,...
Integrated DNA Technologies xGen Hybridization and Wash v3 Kit
Integrated DNA Technologies (IDT) has unveiled its xGen Hybridization and Wash v3 Kit — a...
Cytek Tonbo Reagents
Cytek Tonbo Reagents are designed to enable high-quality research without breaking the budget....